Literature DB >> 8143506

Contribution of differences in plasma binding of propranolol to ethnic differences in sensitivity. Comparison between Chinese and Caucasians.

H H Zhou1, S D Shay, A J Wood.   

Abstract

Chinese are more sensitive to the beta-blocking and hypotensive effects of propranolol than Caucasians. To determine the contribution of ethnic differences in the plasma binding of propranolol to the differences in sensitivity, 8 Caucasians (22.8 +/- 1.5 yr) and 8 Chinese (31.8 +/- 2.1 yr) were studied following single doses of 0, 10, 20, 40 and 80 mg propranolol orally. The binding of propranolol in plasma was determined by equilibrium dialysis after addition of 300 mg racemic propranolol to the plasma. The concentrations of free and bound (+) and (-)-propranolol were determined by stereospecific high performance liquid chromatography (HPLC). Dosage had no influence on the plasma binding of either enantiomer. The unbound fractions of both (-)-propranolol (16.06 +/- 0.79% vs 12.41 +/- 0.93%, P < 0.05) and (+)-propranolol (17.73 +/- 0.81% vs 14.33 +/- 0.89%, P < 0.01) were greater in Chinese than Caucasians, respectively. In both groups, the ratio of unbound (-) to (+)-propranolol was less than 1 (P < 0.01) and was greater in Chinese (0.91 +/- 0.01 vs 0.88 +/- 0.01) (P < 0.01), implying that in Chinese less isomers of both types were bound and there was a greater unbound proportion of the pharmacologically active (-)-propranolol which may contribute to their increased sensitivity to propranolol. It is demonstrated that ethnic differences in stereoselective protein binding may be an important variable in interindividual determinants of drug response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8143506

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Stereoselective urinary excretion of S-(-)- and R-(+)-propranolol glucuronide following oral administration of RS-propranolol in Chinese Han subjects.

Authors:  Lian-Jun Luan; Qing Shao; Jian-Yin Ma; Su Zeng
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

2.  Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.

Authors:  Xiaorong Ma; Tinghui Zhao; Yan Xiao; Jie Yu; Huiping Chen; Yinying Huang; Jun Liu; Jun Lin; Tianxiang Ouyang
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

3.  Comparison of Effectiveness of Two Different Doses of Propranolol on Kaposiform Hemangioendothelioma.

Authors:  Li Wei; Li Li; Zigang Xu; Bin Zhang; Xiaofeng Han; Chen Wang; Yuanxiang Liu; Bingyu Xiu; Lei Qiu; Yujuan Sun; Lin Ma
Journal:  Front Pediatr       Date:  2022-03-28       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.